INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, published by Oxford University Press, stands as a pivotal resource in the domains of Health Policy, Medicine, and Public Health. With an ISSN of 1353-4505 and an E-ISSN of 1464-3677, this journal has been a cornerstone for quality assessment in healthcare since its inception in 1989, evolving through to 2024. Holding a respected position in the academic community, it is classified in the Q2 category across multiple fields including Health Policy and Environmental Health, reflecting its significant impact as evidenced by its Scopus rankings (Rank #74/310 in Health Policy, Percentile 76th). Though it operates under a subscription model, the journal aims to disseminate pioneering research aimed at improving healthcare quality globally, providing insights that are invaluable for researchers, practitioners, and policymakers alike. With a commitment to enhancing public health landscapes, the journal continues to influence practices and outcomes in a rapidly changing health environment.

Drug Healthcare and Patient Safety is a premier Open Access journal, published by DOVE MEDICAL PRESS LTD since 2009, dedicated to advancing the understanding and practices surrounding medication safety and healthcare delivery. With its ISSN 1179-1365 and E-ISSN matching, this New Zealand-based journal not only fosters global discourse but also prioritizes the dissemination of research that intersects both health policy and pharmacology. Categorized as Q2 in Health Policy and Q3 in Pharmacology for the year 2023, it occupies a notable position within the academic community, as reflected by its Scopus rankings, which place it in the 66th and 45th percentiles of its respective categories. Drug Healthcare and Patient Safety aims to provide a platform for researchers, practitioners, and students to share innovative findings, promote safe medication practices, and explore the implications of health policy on patient outcomes. As an Open Access journal, it ensures that vital research is accessible to a wider audience, making significant contributions to the ongoing dialogue in the fields of healthcare and pharmacovigilance.

The British Journal of Anaesthesia is a leading peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing the field of anesthesiology and pain medicine. Since its inception in 1923, this prestigious journal has served as a vital resource for clinicians, researchers, and students, providing high-quality research articles, reviews, and clinical guidelines. With an impressive impact factor and a Scopus rank of #2 out of 136 in its category, it stands out as a Q1 journal, reflecting its significance and influence in the medical community. The journal aims to disseminate innovative research findings, enhance clinical practice, and contribute to the education of healthcare professionals globally. Although it does not offer open access, its rich archive and ongoing publication in the dynamic field of anesthesiology make it an essential reference for those seeking to stay at the forefront of this critical discipline. For more information, visit the journal’s dedicated webpage.

ANESTHESIOLOGY, the premier journal in the field of anesthesiology and pain medicine, is published by Lippincott Williams & Wilkins and holds a prestigious Q1 category ranking as of 2023. With a rich history dating back to 1945, this journal serves as a vital resource for the dissemination of cutting-edge research, expert reviews, and clinical practice guidelines aimed at improving patient care and safety in anesthesia. With a remarkable impact factor and an esteemed ranking of 5 out of 136 in the category of medicine, it showcases work from leading researchers in the field, contributing to a 96th percentile Scopus rank. Although it does not offer open access, ANESTHESIOLOGY provides numerous subscription options that ensure comprehensive access to pivotal findings and advancements that shape modern anesthetic practice. This journal is indispensable for anesthesiologists, clinicians, and researchers dedicated to the innovation and refinement of anesthetic techniques, pain management, and perioperative care.

Pharmaceutical Medicine is a leading journal published by SPRINGER INT PUBL AG, dedicated to the field of pharmacology and pharmaceutical sciences. With ISSN 1178-2595 and E-ISSN 1179-1993, this journal serves as an essential platform for researchers and professionals to share groundbreaking findings and advancements in medication efficacy, safety, and innovative therapeutic strategies. Recognized for its contribution to the field, Pharmaceutical Medicine holds an impressive Q2 ranking in both Pharmacology and Medical Pharmacology categories, further underscored by its competitive Scopus rankings—positioned at 100/272 (63rd percentile) in Medical Pharmacology and 156/313 (50th percentile) in Pharmacology, Toxicology, and Pharmaceutics. Although it primarily operates on a traditional subscription basis, its robust academic reputation continues to attract a diverse readership worldwide. Addressed in the United Kingdom with facilities in Switzerland, the journal publishes authoritative articles from its inception in 2000 through to 2024, making it a pivotal resource for those seeking to enhance their understanding and application of pharmacological principles in clinical practice and research.

American Journal of Medical Quality is a pivotal publication in the field of healthcare quality and medical policy, published by Lippincott Williams & Wilkins. Since its inception in 1992, the journal has become a critical resource for researchers, practitioners, and students dedicated to improving patient care and health systems through evidence-based practices. With a current impact factor that reflects its significance in the arena of medicine and health policy, the journal falls within the Q3 category in both Health Policy and Medicine (Miscellaneous) as of 2023, ranking 253rd out of 636 in general medicine according to Scopus metrics. This underscores its relevance and prominence among peers. The journal's scope encompasses a diverse range of topics related to quality improvement initiatives, healthcare delivery systems, and policy analysis, making it an essential read for anyone invested in advancing medical quality standards and practices. While it is not an open-access journal, the content is meticulously curated to enrich the academic discourse and inform best practices in medical quality. With an ongoing commitment to addressing contemporary challenges in healthcare, American Journal of Medical Quality serves as an influential platform for advancing the knowledge and implementation of quality initiatives in medical settings.

Journal of Pharmaceutical Health Services Research, published by Oxford University Press, stands as a vital resource within the fields of pharmacology, toxicology, and health economics. With a focus on the integration of pharmaceutical science and healthcare services, this journal addresses the rapidly evolving challenges faced by researchers and practitioners alike, promoting innovative solutions that can enhance patient care and improve health outcomes. Its Q3 ranking in key categories such as Economics and Pharmacology further highlights its significance in the academic landscape. Although not an open-access journal, the Journal of Pharmaceutical Health Services Research provides a platform for high-quality research and comprehensive reviews, making it an essential reference for those dedicated to advancing knowledge and practice in pharmaceutical health services. With converged years from 2010 to 2024, the journal continues to contribute valuable insights that foster collaboration among academics, industry professionals, and policymakers, reinforcing its role as a cornerstone of pharmaceutical research and health service innovation.

The Turkish Journal of Anaesthesiology and Reanimation is an esteemed academic publication dedicated to advancing the fields of anesthesiology and pain medicine, as well as emergency medicine. Published by GALENOS PUBL HOUSE, this open access journal has been serving the global academic community since 2019, allowing for unrestricted dissemination of research findings and clinical practices. With its current categorization in the Q3 quartile for both anesthesiology and emergency medicine, the journal provides a valuable platform for researchers, professionals, and students alike, featuring rigorous peer-reviewed articles that enhance knowledge and inspire innovation. Located in Istanbul, Turkey, the journal actively contributes to an important dialogue in healthcare, making it a significant resource for those involved in improving patient care and outcomes. Researchers can also benefit from its increasing visibility, reflected in its Scopus rankings, positioning it within the competitive landscape of medical literature. Engage with cutting-edge research and ensure your contributions stand out in this vital field.

BMJ Open Quality, published by the esteemed BMJ Publishing Group, is an influential open access journal that has been a vital platform for advancing the quality of healthcare since its inception in 2017. Based in the United Kingdom, this journal focuses on a diverse range of topics within health policy, leadership and management, and public health, catering specifically to professionals, researchers, and students eager to explore the intersection of quality improvement and healthcare delivery. With an impressive ranking in Scopus categories, including Q2 in Health Policy and Leadership and Management, BMJ Open Quality fosters a multidisciplinary dialogue that addresses the pressing challenges facing the healthcare sector today. Researchers will find robust access options, allowing for unrestricted sharing of valuable findings, thereby enhancing collaboration and innovation in the field. Positioned at the forefront of quality enhancement methodologies, BMJ Open Quality is indispensable for those dedicated to driving systematic changes in health services.

DRUG SAFETY is a premier academic journal published by ADIS INT LTD, dedicated to the critical field of pharmacology and toxicology. Since its inception in 1990, the journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals by providing high-quality, peer-reviewed articles that inform and advance the understanding of drug safety and efficacy. With an impressive impact factor and its current Q1 categorization in Pharmacology across various sub-disciplines, DRUG SAFETY is ranked among the top journals in its field, reflecting its commitment to excellence in scientific research. The journal features a diverse range of studies, reviews, and case reports addressing contemporary issues in drug safety, making it an invaluable tool for academia and industry alike. Although it is not an open-access journal, the content is accessible to subscribers and institutions, ensuring that essential findings in drug safety reach the widest audience possible. As the field evolves, DRUG SAFETY remains at the forefront, driving innovation and improving regulatory practices worldwide.